In advance of World AIDS Day on 12/1, amfAR joins 103 other advocacy organizations calling Congress not to enact a House-proposed $767 million cut to domestic HIV programs. Please help us #saveHIVfunding by writing to your representatives today: https://t.co/DkWAjcZfQ0
Hans-Peter Kiem, MD, PhD is pursuing an in vivo gene therapy #hivcure that confers resistance to a specific subset of a patient’s hematopoietic stem cells, the building blocks of our blood & immune systems. He was awarded $480,000 by @amfAR to support the next stage of his work.
In past cases of #HIV, #doctors used bone marrow #transplants to transfer #CCR5 T cells into patients’ bodies. However, this method continues to have potentially lethal drawbacks, which is why we need a safe cure for HIV. Read more here. https://t.co/pXjye2mWxx
Dr. He used CRISPR to edit genes of embryos to delete a receptor (CCR5) that enables #HIV to enter cells, mimicking the handful of people cured of HIV after a stem cell transplant from donors with a rare natural CCR5 mutation. 1/
https://t.co/jBF8YKVJLj
NEW webinar series 2023: discuss the needs and concerns around #HIVcure research for people who have lived with #HIV for many years
Register here: https://t.co/EBDrmoc28m
Here is a new webinar series to discuss the needs and concerns around the research towards a cure for HIV specific to people who have lived with #HIV for many years.
Register now at https://t.co/Sj5xZ09KIr
#hivcure
Can we come to a real breakthrough in the #HIV cure? 🤝
We believe so! That's why we've launched the multi-disciplinary ‘HIV Cure For Everyone’ programme with @NWONieuws & @ZonMw.
What is it & why does it matter? 👇 #HIVCure
https://t.co/oN2uNKNZSA
@Aidsfonds
Reminder: Join #FDA for a listening meeting on April 27 to hear stakeholder input on methods and approaches for capturing post-approval #safety and efficacy data on cell and #GeneTherapy products. This event is free and open to the public. Register here: https://t.co/hBO1GbhlnR
📣 Applications are due in just 1 week for the 2023 Research-for-Cure Academy.
The academy is designed for people in countries with limited resources for #HIV cure research who are interested in working towards an #HIVcure.
✅ Learn more & apply today! https://t.co/DKPZhhwkN5
“…we are at a crossroads in the cell and gene therapy industry…decentralization will make cell and gene therapies more attainable for more patients…” -Ø Åmellem, Thermo Fisher director of cell therapy @globalgti@amfAR@thermofisher@Cytiva in https://t.co/UNO7ZKJYCX
Very True! Its easy for those who aren't dirrectly affected by this deadly virus!
More needs to be done! We can no longer ignore it! The science is HERE, to CureHIVNOW!
@amfAR@NIH@POTUS@NIHFunding@caring_cross@CRISPRForCure
"It’s very easy to think that #HIV has gone away, that it’s no longer a big problem. It is still a major #pandemic. People still die. A cure would be transformative." – IAS President @ProfSharonLewin
Listen to Episode 5 of #HIVunmuted now: https://t.co/KHPbpWMDhn
HIV stigma can keep people from getting tested and treated for #HIV. Let’s #StopHIVStigma by learning and sharing the facts together.
Join the conversation: https://t.co/0wPJCrngBr
#StopHIVTogether
Two clinical trials show that giving a single infusion of genetically modified CD4 cells increased CD4 count, reduced the size of the #HIV reservoir, and controlled viral loads over durations lasting weeks to years.
https://t.co/x9VfHiqOBt
#hivcure
@defeatHIV@HIVcureAU Probably because ART (Antiretrovirals) cant cross the BBB (Blood Brain Barrier) ? Unlike bNabs. More research needs to be done in this area! https://t.co/zIbq27YjaH https://t.co/rqnY2OXgD1